Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial
Crossref DOI link: https://doi.org/10.1186/s13075-015-0721-3
Published Online: 2015-08-18
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gordon, Jessica K.
Martyanov, Viktor
Magro, Cynthia
Wildman, Horatio F.
Wood, Tammara A.
Huang, Wei-Ti
Crow, Mary K.
Whitfield, Michael L.
Spiera, Robert F.